Innovex International (INVX) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
2 Dec, 2025Executive summary
Annual meeting scheduled for May 14, 2025, with virtual participation options and multiple voting methods available.
Key proposals include director elections, an amendment to increase authorized common stock, adoption of a new long-term incentive plan, auditor appointment, and a say-on-pay advisory vote.
The company completed a significant merger in September 2024, resulting in a new corporate structure and leadership team.
As of March 18, 2025, there were 69,368,100 shares of common stock outstanding, each entitled to one vote.
Voting matters and shareholder proposals
Proposal 1: Election of three Class I directors for a three-year term expiring in 2028.
Proposal 2: Amendment to increase authorized common stock from 100 million to 200 million shares.
Proposal 3: Adoption of the 2025 Long-Term Incentive Plan, authorizing up to 5 million shares for equity awards.
Proposal 4: Appointment of PricewaterhouseCoopers LLP as independent auditor for 2025.
Proposal 5: Advisory vote to approve executive compensation (say-on-pay).
No shareholder proposals or director nominations were received for this meeting.
Board of directors and corporate governance
Board is majority independent, with separate CEO and Chair roles.
Three standing committees: Audit, Compensation, and Nominating & Governance, each with defined charters and independent members.
Board diversity is promoted, and all directors are in compliance with stock ownership guidelines.
Regular executive sessions are held without management present.
Board members attended at least 75% of meetings in 2024.
Latest events from Innovex International
- Q4 revenue up 14% sequentially, strong cash flow, and margin expansion expected in 2026.INVX
Q4 202524 Feb 2026 - Q3 revenue up 17% to $152M; $83M net income and $15M synergies highlight merger impact.INVX
Q3 202415 Jan 2026 - Post-merger registration allows resale of 44% of shares, with no proceeds to the company.INVX
Registration Filing16 Dec 2025 - Annual meeting to vote on directors, share increase, LTIP, auditor, and executive pay.INVX
Proxy Filing2 Dec 2025 - Annual meeting to vote on directors, share increase, incentives, auditor, and pay.INVX
Proxy Filing2 Dec 2025 - Q3 2025 revenue up 58% YoY to $240M, with strong cash flow and major acquisitions completed.INVX
Q3 202513 Nov 2025 - Q2 2025 revenue surged 72% YoY to $224.2M, fueled by acquisitions and global expansion.INVX
Q2 20256 Aug 2025 - Revenue up 34% to $120.3M; Innovex merger expected to close in Q3 2024.INVX
Q2 202413 Jun 2025 - Q1 2025 saw strong growth and cash flow, but margins declined amid integration costs.INVX
Q1 20259 Jun 2025